)
)
Akoya Biosciences Investor Relations Material
Latest events
Q3 2024
Akoya Biosciences
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Akoya Biosciences Inc
Access all reports
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research. The company offers DyScribe In Situ Protein Synthesis Kit for in situ protein synthesis to enable scientists to study the proteome; and Akoya Preclinical, which is an in vivo visualization and signaling platform that enables scientists to visualize and precisely measure signal activation at the single cell level. It also provides Akoya XSpatial Platform for research, diagnostics, and bio-manufacturing applications. The company was founded in 2011 and is headquartered in Cambridge, Massachusetts.
Latest articles
)
Robert G. Hagstrom: Darwinian Investing and Multidisciplinary Wisdom
Robert G. Hagstrom, author of The Warren Buffett Way, explores how interdisciplinary thinking shapes his investing, from Adler's reading to Darwinian markets.
7 Feb 2025
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Ticker symbol
AKYA
Country
🇺🇸 United States